Brief: Assembly Biosciences - Effective May 20, Because Of Clinical Hold On Ati-2173, Co Terminated Clinical Trial Collaboration Agreement With Antios

Assembly Biosciences

24/05/2022 23:37

May 24 (Reuters) - Assembly Biosciences Inc  ASMB.O :
    * ASSEMBLY BIOSCIENCES - EFFECTIVE MAY 20, BECAUSE OF
CLINICAL
HOLD ON ATI-2173, CO TERMINATED CLINICAL TRIAL COLLABORATION
AGREEMENT WITH ANTIOS

Further company coverage:  ASMB.O 

 ((Reuters.Briefs@thomsonreuters.com;))